Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial.
第一作者:
Hiddo J L,Heerspink
第一单位:
Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. Electronic address: h.j.lambers.heerspink@umcg.nl.
作者:
主题词
老年人(Aged);白蛋白尿(Albuminuria);酰胺类(Amides);血管紧张素受体拮抗剂(Angiotensin Receptor Antagonists);抗高血压药(Antihypertensive Agents);肌酸酐(Creatinine);糖尿病, 2型(Diabetes Mellitus, Type 2);双盲法(Double-Blind Method);女(雌)性(Female);随访研究(Follow-Up Studies);延胡索酸盐类(Fumarates);肾小球滤过率(Glomerular Filtration Rate);人类(Humans);肾功能衰竭, 慢性(Kidney Failure, Chronic);男(雄)性(Male);荷兰(Netherlands);患病率(Prevalence);预后(Prognosis);存活率(Survival Rate)
DOI
10.1016/S2213-8587(15)00469-6
PMID
26774608
发布时间
2022-03-10
- 浏览17

The lancet. Diabetes & endocrinology
2016年4卷4期
309-17页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文